Interrupted Aortic Arch (IAA)

01Pathophysiology

Interrupted aortic arch (IAA) is a congenital cardiac defect characterized by complete anatomic discontinuity of the aortic arch. Unlike coarctation, where a narrowing exists but some luminal continuity remains, IAA involves a full gap in the arch. This means the ascending aorta and the descending aorta are physically separated, and blood cannot flow from one to the other through the arch itself.

During fetal life, this defect is well tolerated because the ductus arteriosus serves as the bridge. Blood ejected from the right ventricle into the pulmonary artery crosses the patent ductus arteriosus (PDA) and supplies the descending aorta, perfusing the lower body, kidneys, and gut. The fetus remains hemodynamically stable because ductal flow compensates entirely for the absent arch segment.

The crisis begins after birth when the ductus arteriosus undergoes physiologic closure, typically within the first 24 to 72 hours of life. As the duct constricts, systemic perfusion to the lower body is abruptly cut off. The kidneys become ischemic, the gut is underperfused, and the neonate develops progressive lactic acidosis from anaerobic metabolism in the lower body. Simultaneously, the left ventricle faces an enormous afterload because all cardiac output must now be directed through whatever proximal arch exists, leading to rapid-onset congestive heart failure with pulmonary edema.

Nearly all cases of IAA are associated with a ventricular septal defect (VSD), which is present in over 95% of patients. The VSD allows some degree of intracardiac mixing but does not prevent the hemodynamic catastrophe that occurs once the ductus closes. The VSD is an important associated finding because it influences the surgical approach.

The strong link to 22q11.2 microdeletion (DiGeorge syndrome) is a high-yield association. This chromosomal abnormality affects neural crest cell migration, which is critical for the development of the aortic arch derivatives, the thymus, and the parathyroid glands. A neonate with IAA who also has hypocalcemia (from absent parathyroids), T-cell lymphopenia (from thymic hypoplasia), and characteristic facial features should immediately prompt genetic testing for 22q11.2 deletion.

02Classification and Clinical Manifestation

Celoria-Patton Classification

The hallmark physical finding is differential pulse quality and blood pressure between the upper and lower extremities.

• In Type A, the right arm, left arm, and head all receive flow from the ascending aorta, while the lower body depends on ductal flow.

• In Type B, the left subclavian artery arises distal to the interruption, so the left arm may also have diminished pulses, creating an asymmetry even between the two upper extremities. This is a testable nuance that distinguishes Type B from Type A and from coarctation.

By Timing

03Diagnostic Workup

Echocardiography is both the best initial test and often the definitive diagnostic study. In an acutely ill neonate with absent femoral pulses and metabolic acidosis, bedside echocardiography can rapidly identify the arch discontinuity, demonstrate retrograde flow through the PDA into the descending aorta, and characterize the associated VSD. This is the study that should be ordered first.

The four-limb blood pressure and pulse oximetry assessment is a bedside screening maneuver. A saturation difference between the right hand (pre-ductal) and the feet (post-ductal) greater than 3% suggests ductal-dependent lower body perfusion. This can also be picked up on routine newborn pulse oximetry screening, which is why critical congenital heart disease screening programs exist.

CT angiography or cardiac MRI is reserved for cases where echocardiography does not provide adequate anatomic detail or when the surgical team needs precise three-dimensional reconstruction of the arch anatomy. These are not first-line tests in the acute setting.

Genetic evaluation should not be delayed. Given that up to 50% of Type B IAA patients carry the 22q11.2 deletion, fluorescence in situ hybridization (FISH) or chromosomal microarray should be sent early. The presence of DiGeorge syndrome has implications for surgical planning (irradiated blood products to prevent graft-versus-host disease due to T-cell immunodeficiency), calcium management, and long-term follow-up.

04Management and Treatment

PGE1 is the single most critical initial intervention. The moment IAA is suspected, PGE1 must be started without waiting for echocardiographic confirmation. The drug relaxes the smooth muscle of the ductus arteriosus, reopening it and restoring blood flow to the descending aorta. Clinically, you will see the femoral pulses return, urine output improve, and the lactate begin to clear. The most important side effect to monitor is apnea, which occurs in 10-12% of neonates on PGE1 and necessitates elective intubation in many centers before transport.

Metabolic acidosis should be corrected with careful fluid resuscitation and, if severe, sodium bicarbonate. Hypocalcemia must be checked and corrected promptly, particularly because unrecognized DiGeorge syndrome can cause refractory hypocalcemia that worsens cardiac contractility and contributes to hemodynamic instability.

Surgical repair is performed as a single-stage procedure in most centers: the arch is reconstructed by direct end-to-end anastomosis (or with a homograft patch if the gap is too wide), and the VSD is closed simultaneously through a median sternotomy. The surgery is typically performed within the first 1 to 2 weeks of life, once the neonate is stabilized.

Contraindication to keep in mind: If a neonate with IAA and confirmed DiGeorge syndrome requires blood transfusion (perioperatively or otherwise), all blood products must be irradiated and CMV-negative to prevent transfusion-associated graft-versus-host disease, given the underlying T-cell immunodeficiency.

Long-term complications include re-coarctation at the surgical repair site (the most common late complication, occurring in up to 25% of patients), subaortic stenosis from the VSD patch or left ventricular outflow tract narrowing, and aortic valve disease. These patients require lifelong cardiology follow-up.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students get this topic wrong is by confusing IAA with coarctation of the aorta. Both conditions involve the aortic arch, both can present with differential pulses, and both can be ductal-dependent in neonates. The critical distinction is that coarctation is a narrowing with preserved continuity, while IAA is a complete anatomic gap. On the exam, if a vignette describes a neonate with total absence of femoral pulses (not just diminished), severe metabolic acidosis within the first 48-72 hours, and associated findings of hypocalcemia or immunodeficiency, this points to IAA rather than coarctation.

Another trap is failing to connect IAA to DiGeorge syndrome. When a vignette describes a neonate with a cardiac defect plus hypocalcemic seizures, absent thymic shadow on chest X-ray, or recurrent infections, students may focus on the cardiac lesion and miss the unifying diagnosis of 22q11.2 deletion. The test-writer expects you to recognize the constellation: cardiac defect (IAA Type B, truncus, or tetralogy of Fallot) + hypocalcemia + immunodeficiency = DiGeorge.

A third pitfall involves PGE1. Students sometimes hesitate to start PGE1 before obtaining echocardiographic confirmation. On the exam, the correct answer is always to start PGE1 immediately in any neonate with suspected ductal-dependent circulation, then confirm with echocardiography. Waiting for imaging in a crashing neonate is never the right answer. The core competency being tested here is the ability to recognize a ductal-dependent cardiac emergency, initiate life-saving pharmacologic stabilization, and then sequence the diagnostic workup and definitive surgical management appropriately.